Pierre Laurent-Puig
Pierre Laurent-Puig
Unisveristé Paris Descartes
Verified email at parisdescartes.fr
Cited by
Cited by
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
JP Hugot, M Chamaillard, H Zouali, S Lesage, JP Cézard, J Belaiche, ...
Nature 411 (6837), 599-603, 2001
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lievre, JB Bachet, D Le Corre, V Boige, B Landi, JF Emile, JF Côté, ...
Cancer research 66 (8), 3992-3995, 2006
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ French, ...
New England Journal of Medicine 349 (3), 247-257, 2003
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350, 2015
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective …
W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ...
The lancet oncology 11 (8), 753-762, 2010
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
A Lievre, JB Bachet, V Boige, A Cayre, D Le Corre, E Buc, M Ychou, ...
Journal of clinical oncology 26 (3), 374-379, 2008
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
Mapping of a susceptibility locus for Crohn's disease on chromosome 16
JP Hugot, P Laurent-Puig, C Gower-Rousseau, JM Olson, JC Lee, ...
Nature 379 (6568), 821-823, 1996
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ...
Nature genetics 45 (4), 353-361, 2013
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study
HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ...
British journal of cancer 85 (5), 692-696, 2001
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
S Boyault, DS Rickman, A De Reyniès, C Balabaud, S Rebouissou, ...
Hepatology 45 (1), 42-52, 2007
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value
L Marisa, A de Reyniès, A Duval, J Selves, MP Gaub, L Vescovo, ...
PLoS Med 10 (5), e1001453, 2013
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
P Laurent-Puig, A Cayre, G Manceau, E Buc, JB Bachet, T Lecomte, ...
Journal of clinical oncology 27 (35), 5924-5930, 2009
Alleles of the APC gene: an attenuated form of familial polyposis
L Spirio, S Olschwang, J Groden, M Robertson, W Samowitz, G Joslyn, ...
Cell 75 (5), 951-957, 1993
Genotype–phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC
J Zucman‐Rossi, E Jeannot, JT Van Nhieu, JY Scoazec, C Guettier, ...
Hepatology 43 (3), 515-524, 2006
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
P Laurent–Puig, P Legoix, O Bluteau, J Belghiti, D Franco, F Binot, ...
Gastroenterology 120 (7), 1763-1773, 2001
Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability
B Mlecnik, G Bindea, HK Angell, P Maby, M Angelova, D Tougeron, ...
Immunity 44 (3), 698-711, 2016
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
Quantitative and sensitive detection of rare mutations using droplet-based microfluidics
D Pekin, Y Skhiri, JC Baret, D Le Corre, L Mazutis, CB Salem, F Millot, ...
Lab on a Chip 11 (13), 2156-2166, 2011
Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity
L Bodin, C Verstuyft, DA Tregouet, A Robert, L Dubert, C Funck-Brentano, ...
Blood 106 (1), 135-140, 2005
The system can't perform the operation now. Try again later.
Articles 1–20